Yanping Wu

1.5k total citations · 2 hit papers
17 papers, 999 citations indexed

About

Yanping Wu is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Yanping Wu has authored 17 papers receiving a total of 999 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 10 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Yanping Wu's work include Asthma and respiratory diseases (14 papers), Respiratory and Cough-Related Research (7 papers) and Eosinophilic Esophagitis (4 papers). Yanping Wu is often cited by papers focused on Asthma and respiratory diseases (14 papers), Respiratory and Cough-Related Research (7 papers) and Eosinophilic Esophagitis (4 papers). Yanping Wu collaborates with scholars based in United States, Canada and Japan. Yanping Wu's co-authors include Roland Kolbeck, William W. Busse, Sally E. Wenzel, Néstor A. Molfino, David Gossage, Eugene R. Bleecker, Rohit Katial, Ron Olivenstein, Gail M. Gauvreau and Michel Laviolette and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, European Respiratory Journal and The Lancet Respiratory Medicine.

In The Last Decade

Yanping Wu

17 papers receiving 982 citations

Hit Papers

Effects of benralizumab on airway eosinophils in asthmati... 2013 2026 2017 2021 2013 2014 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia
    2013 370 citations Michel Laviolette, David Gossage et al. Journal of Allergy and Clinical Immunology profile →
  2. Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study
    2014 362 citations Mario Castro, Sally E. Wenzel et al. The Lancet Respiratory Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanping Wu United States 7 920 628 275 260 250 17 999
M Gilson United Kingdom 8 659 0.7× 478 0.8× 169 0.6× 237 0.9× 179 0.7× 14 802
Yoriyuki Murata Japan 10 166 0.2× 228 0.4× 35 0.1× 44 0.2× 40 0.2× 36 333
R A Helmers United States 8 295 0.3× 866 1.4× 29 0.1× 71 0.3× 9 0.0× 8 921
Shigeki Kuroishi Japan 12 136 0.1× 278 0.4× 21 0.1× 126 0.5× 4 0.0× 24 449
Raphaël Lhote France 11 143 0.2× 122 0.2× 53 0.2× 32 0.1× 5 0.0× 25 372
Eduardo Talesnik Chile 10 21 0.0× 44 0.1× 72 0.3× 118 0.5× 21 0.1× 30 301
Francesca Brunini Italy 9 12 0.0× 158 0.3× 92 0.3× 51 0.2× 29 0.1× 12 297
Akiko Fujiwara Japan 10 47 0.1× 52 0.1× 32 0.1× 71 0.3× 33 0.1× 28 320
Kristen Cox United States 10 21 0.0× 132 0.2× 108 0.4× 497 1.9× 60 0.2× 19 562
Lisa Lawrence-Miyasaki United States 5 44 0.0× 78 0.1× 33 0.1× 172 0.7× 18 0.1× 7 458

Countries citing papers authored by Yanping Wu

Since Specialization
Citations

This map shows the geographic impact of Yanping Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanping Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanping Wu more than expected).

Fields of papers citing papers by Yanping Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanping Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanping Wu. The network helps show where Yanping Wu may publish in the future.

Co-authorship network of co-authors of Yanping Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanping Wu. A scholar is included among the top collaborators of Yanping Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanping Wu. Yanping Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Ferguson, Gary T., Adel Mansur, Joshua Jacobs, et al.. (2018). Assessment of an accessorized pre-filled syringe for home-administered benralizumab in severe asthma. Journal of Asthma and Allergy. Volume 11. 63–72. 23 indexed citations
3.
Bleecker, Eugene R., Michael E. Wechsler, J. Mark FitzGerald, et al.. (2018). Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma. European Respiratory Journal. 52(4). 1800936–1800936. 172 indexed citations
4.
DuBuske, L., Paul Newbold, Yanping Wu, Frank Trudo, & Gokul Gopalan. (2018). Seasonal Variability of Exacerbations in Patients With Severe, Uncontrolled Eosinophilic Asthma and Clinical Benefits of Benralizumab: Pooled Analysis of the SIROCCO and CALIMA Trials. Journal of Allergy and Clinical Immunology. 141(2). AB12–AB12. 1 indexed citations
5.
DuBuske, L., Paul Newbold, Yanping Wu, & Frank Trudo. (2018). Seasonal variability of exacerbations of severe, uncontrolled eosinophilic asthma and clinical benefits of benralizumab. Allergy and Asthma Proceedings. 39(5). 345–349. 14 indexed citations
6.
Park, Hae‐Sim, Sang Haak Lee, Viktoría Werkström, et al.. (2018). Benralizumab Reduces Exacerbations and Improves Lung Function in Patients From Republic of Korea With Severe, Uncontrolled Asthma: Subgroup Analysis of the SIROCCO Trial. Journal of Allergy and Clinical Immunology. 141(2). AB14–AB14. 1 indexed citations
7.
Máspero, Jorge, Tim Harrison, Viktoría Werkström, et al.. (2018). Clinical Efficacy of Benralizumab in Patients With Severe, Uncontrolled Eosinophilic Asthma and Nasal Polyposis: Pooled Analysis of the SIROCCO and CALIMA Trials. Journal of Allergy and Clinical Immunology. 141(2). AB12–AB12. 19 indexed citations
8.
FitzGerald, J Mark, Ken Ohta, Mitsuru Adachi, et al.. (2017). Benralizumab Reduces Exacerbations in Japanese Patients with Severe, Uncontrolled Asthma: Subgroup Analysis of the Calima Trial. Journal of Allergy and Clinical Immunology. 139(2). AB10–AB10. 1 indexed citations
9.
Wei, Juan, Jieying Liu, & Yanping Wu. (2017). Correlation between the fear related to childbirth and the social support in pregnant women. ˜The œJournal of practical nursing. 33(10). 752–754. 1 indexed citations
10.
Ohta, Ken, Mitsuru Adachi, Yuji Tohda, et al.. (2017). Efficacy and safety of benralizumab in Japanese patients with severe, uncontrolled eosinophilic asthma. Allergology International. 67(2). 266–272. 21 indexed citations
11.
12.
13.
Ferguson, Gary T., J. Mark FitzGerald, Eugene R. Bleecker, et al.. (2016). LATE-BREAKING ABSTRACT: Benralizumab for mild to moderate, persistent asthma: The BISE phase III study. OA1791–OA1791. 1 indexed citations
14.
Castro, Mario, Sally E. Wenzel, Roland Kolbeck, et al.. (2014). Late-breaking abstract: A phase 2 study of benralizumab on exacerbations, lung function, and asthma control in adults with uncontrolled eosinophilic asthma. European Respiratory Journal. 44(Suppl 58). 2909–2909. 3 indexed citations
15.
Castro, Mario, Sally E. Wenzel, Eugene R. Bleecker, et al.. (2014). Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study. The Lancet Respiratory Medicine. 2(11). 879–890. 362 indexed citations breakdown →
16.
Laviolette, Michel, David Gossage, Gail M. Gauvreau, et al.. (2013). Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia. Journal of Allergy and Clinical Immunology. 132(5). 1086–1096.e5. 370 indexed citations breakdown →
17.
Gossage, David, Michel Laviolette, Gail M. Gauvreau, et al.. (2012). Depletion Of Airway Eosinophils By Benralizumab An Anti-IL5 Receptor Alpha Monoclonal Antibody. A3961–A3961. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Gilson Breakdown of academic impact, for papers by Yoriyuki Murata Breakdown of academic impact, for papers by R A Helmers Breakdown of academic impact, for papers by Shigeki Kuroishi Breakdown of academic impact, for papers by Raphaël Lhote Breakdown of academic impact, for papers by Eduardo Talesnik Breakdown of academic impact, for papers by Francesca Brunini Breakdown of academic impact, for papers by Akiko Fujiwara Breakdown of academic impact, for papers by Kristen Cox Breakdown of academic impact, for papers by Lisa Lawrence-Miyasaki
Rankless by CCL
2026